36624932|t|In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G  mutant mouse model of Parkinson's disease.
36624932|a|BACKGROUND: Leucine-rich repeat kinase 2 (LRRK2) mutation is a common genetic risk factor of Parkinson's disease (PD). Presynaptic dysfunction is an early pathogenic event associated with dopamine (DA) dysregulation in striatum of the brain. DA uptake activity of DA uptake transporter (DAT) affects synaptic plasticity and motor and non-motor behavior. Synaptogyrin-3 (SYNGR3) is part of the synaptogyrin family, especially abundant in brain. Previous in vitro studies demonstrated interaction between SYNGR3 and DAT. Reduced SYNGR3 expression was observed in human PD brains with unclear reasons. METHODS: Here, we further explored whether inducing SYNGR3 expression can influence (i) cellular DA uptake using differentiated human SH-SY5Y neuronal cells, (ii) striatal synaptosomal DA uptake in a mutant LRRK2R1441G  knockin mouse model of PD, and (iii) innate rodent behavior using the marble burying test. RESULTS: Young LRRK2 mutant mice exhibited significantly lower SYNGR3 levels in striatum compared to age-matched wild-type (WT) controls, resembling level in aged WT mice. SYNGR3 is spatially co-localized with DAT at striatal presynaptic terminals, visualized by immuno-gold transmission electron microscopy and immunohistochemistry. Their protein-protein interaction was confirmed by co-immunoprecipitation. Transient overexpression of SYNGR3 in differentiated SH-SY5Y cells increased cellular DA uptake activity without affecting total DAT levels. Inducing SYNGR3 overexpression by adeno-associated virus-7 (AAV7) injection in vivo into striatum increased ex vivo synaptosomal DA uptake in LRRK2 mutant mice and improved their innate marble burying behavior. CONCLUSION: Brain SYNGR3 expression may be an important determinant to striatal DA homeostasis and synaptic function. Our preliminary behavioral test showed improved innate behavior after SYNGR3 overexpression in LRRK2 mutant mice, advocating further studies to determine the influence of SYNGR3 in the pathophysiology of DA neurons in PD.
36624932	26	40	synaptogyrin-3	Gene	20974
36624932	68	76	dopamine	Chemical	MESH:D004298
36624932	107	112	mouse	Species	10090
36624932	122	141	Parkinson's disease	Disease	MESH:D010300
36624932	155	183	Leucine-rich repeat kinase 2	Gene	66725
36624932	185	190	LRRK2	Gene	66725
36624932	236	255	Parkinson's disease	Disease	MESH:D010300
36624932	257	259	PD	Disease	MESH:D010300
36624932	331	339	dopamine	Chemical	MESH:D004298
36624932	341	343	DA	Chemical	MESH:D004298
36624932	385	387	DA	Chemical	MESH:D004298
36624932	407	428	DA uptake transporter	Gene	13162
36624932	430	433	DAT	Gene	13162
36624932	497	511	Synaptogyrin-3	Gene	9143
36624932	513	519	SYNGR3	Gene	9143
36624932	646	652	SYNGR3	Gene	9143
36624932	657	660	DAT	Gene	6531
36624932	670	676	SYNGR3	Gene	9143
36624932	704	709	human	Species	9606
36624932	710	712	PD	Disease	MESH:D010300
36624932	794	800	SYNGR3	Gene	20974
36624932	839	841	DA	Chemical	MESH:D004298
36624932	870	875	human	Species	9606
36624932	876	883	SH-SY5Y	CellLine	CVCL:0019
36624932	927	929	DA	Chemical	MESH:D004298
36624932	970	975	mouse	Species	10090
36624932	985	987	PD	Disease	MESH:D010300
36624932	1068	1073	LRRK2	Gene	66725
36624932	1081	1085	mice	Species	10090
36624932	1116	1122	SYNGR3	Gene	20974
36624932	1219	1223	mice	Species	10090
36624932	1225	1231	SYNGR3	Gene	20974
36624932	1263	1266	DAT	Gene	13162
36624932	1490	1496	SYNGR3	Gene	9143
36624932	1515	1522	SH-SY5Y	CellLine	CVCL:0019
36624932	1548	1550	DA	Chemical	MESH:D004298
36624932	1591	1594	DAT	Gene	6531
36624932	1612	1618	SYNGR3	Gene	20974
36624932	1637	1642	adeno	Chemical	-
36624932	1732	1734	DA	Chemical	MESH:D004298
36624932	1745	1750	LRRK2	Gene	66725
36624932	1758	1762	mice	Species	10090
36624932	1832	1838	SYNGR3	Gene	9143
36624932	1894	1896	DA	Chemical	MESH:D004298
36624932	2002	2008	SYNGR3	Gene	20974
36624932	2027	2032	LRRK2	Gene	66725
36624932	2040	2044	mice	Species	10090
36624932	2103	2109	SYNGR3	Gene	20974
36624932	2136	2138	DA	Chemical	MESH:D004298
36624932	2150	2152	PD	Disease	MESH:D010300
36624932	Association	MESH:D004298	13162
36624932	Bind	13162	20974
36624932	Association	MESH:D004298	MESH:D010300
36624932	Negative_Correlation	MESH:D010300	9143
36624932	Association	20974	66725
36624932	Positive_Correlation	MESH:D004298	9143
36624932	Association	6531	9143
36624932	Association	MESH:D010300	66725
36624932	Association	MESH:D010300	20974
36624932	Association	MESH:D004298	66725
36624932	Association	MESH:D004298	20974

